Graf Akcie AMED (Amedisys Inc.). Diskuze k akciím AMED. Aktuální informace AMED.

Základní informace o společnosti Amedisys Inc. (Akcie AMED)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 4.75B
Hodnota podniku (EV) 5.51B
Tržby 2.196B
EBITDA 279.126M
Zisk 247.151M
Růst v tržbách Q/Q 16.31 %
Růst v tržbách Y/Y 11.36 %
P/E (Cena vůči ziskům) 19.37
Forward P/E 6.28
EV/Sales 2.51
EV/EBITDA 19.74
EV/EBIT 17.84
PEG 1.80
Price/Sales 2.16
P/FCF 17.95
Price/Book 5.86
Účetní hodnota na akcii 24.97
Hotovost na akcii 2.57
FCF vůči ceně 5.57 %
Počet zaměstnanců 2,020
Tržba na zaměstnance 1087000
Profit margin 8.86 %
Operating margin 12.41 %
Gross margin 42.78 %
EBIT margin 14.07 %
EBITDA margin 12.71 %
EPS - Zisk na akcii 7.56
EPS - Kvartální růst 26.12 %
EPS - Očekávaný růst příští rok -39.29 %
Return on assets 15.59 %
Return on equity 30.63 %
ROIC 15.58 %
ROCE 26.86 %
Dluhy/Equity 0.93
Čistý dluh/EBITDA 3.44
Current ratio 0.87
Quick Ratio 0.87
Volatilita 3.80
Beta 0.78
RSI 27.37
Cílová cena analytiků 281
Známka akcie (dle analytiků) 1.53
Insider ownership 1.53 %
Institutional ownership 89.15 %
Počet akcií 32.632M
Procento shortovaných akcií 1.96 %
Short ratio 2.79 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk 0.00 %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie AMED

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,955.633$1,662.578$1,511.272$1,419.261$1,280.541$1,204.554
Cost Of Goods Sold$1,150.337$992.863$903.377$834.381$725.915$691.061
Gross Profit$805.296$669.715$607.895$584.88$554.626$513.493
Research And Development Expenses------
SG&A Expenses$607.926$501.306$482.213$503.43$452.435$441.738
Other Operating Income Or Expenses$-1.47-$-30.035$-4.432$-91.321$-19.401
Operating Expenses$1,778.161$1,507.43$1,432.748$1,361.921$1,289.707$1,180.507
Operating Income$177.472$155.148$78.524$57.34$-9.166$24.047
Total Non-Operating Income/Expense$-7.062$3.84$2.277$4.226$8.858$-3.071
Pre-Tax Income$170.41$158.988$80.801$61.566$-0.308$20.976
Income Taxes$42.503$38.859$50.118$23.935$2.004$7.671
Income After Taxes$127.907$120.129$30.683$37.631$-2.312$13.305
Other Income------
Income From Continuous Operations$127.907$120.129$30.683$37.631$-2.312$13.305
Income From Discontinued Operations-----$-0.216
Net Income$126.833$119.346$30.301$37.261$-3.021$12.776
EBITDA$232.678$169.206$96.382$77.758$11.829$53.191
EBIT$177.472$155.148$78.524$57.34$-9.166$24.047
Basic Shares Outstanding323334333332
Shares Outstanding333434343333
Basic EPS$3.95$3.64$0.90$1.12$-0.09$0.39
EPS - Earnings Per Share$3.84$3.55$0.88$1.10$-0.09$0.39
# 2020 2019 2018 2017 2016 2015
Current Ratio1.07221.00741.44681.18511.00040.8351
Long-term Debt / Capital0.26580.01180.13150.160.18250.2079
Debt/Equity Ratio0.37750.01530.1720.20170.23540.2926
Gross Margin41.178340.281740.224141.210243.311942.6293
Operating Margin9.07499.33185.19594.0401-0.71581.9963
EBIT Margin9.07499.33185.19594.0401-0.71581.9963
EBITDA Margin11.897810.17736.37755.47880.92374.4158
Pre-Tax Profit Margin8.71389.56275.34664.3379-0.02411.7414
Net Profit Margin6.48557.17842.0052.6254-0.23591.0606
Asset Turnover1.54872.31841.85781.93351.87841.7985
Inventory Turnover Ratio------
Receiveable Turnover8.23098.7987.51148.546910.243512.1274
Days Sales In Receivables44.34541.486648.592542.705635.632330.0971
ROE - Return On Equity19.938324.89035.94148.1604-0.56333.345
Return On Tangible Equity-156.4899110.188920.398830.0016-2.20778.3689
ROA - Return On Assets10.129316.75163.77185.1266-0.33911.9866
ROI - Return On Investment14.638524.5965.166.8551-0.46052.6497
Book Value Per Share19.870915.094615.204713.725712.212811.8399
Operating Cash Flow Per Share-0.52643.56731.237-1.41925.261-5.2693
Free Cash Flow Per Share-0.57483.68191.4092-1.8355.5876-4.3578

Porovnání s konkurencí: Akcie AMED

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
AMED 19.37 1.80 11.36 % -39.29 % 30.63 % 5.86 8.86 %
Akcie CHE 21.88 2.72 4.96 % -7.00 % 34.65 % 7.44 15.36 %

Nedávné obchody insiderů: Akcie AMED

Jméno Obchod Cena Objem
Bruce D Perkins
Director
Nákup
1 Mar 2021
$259.38 $259,380
Scott G Ginn
EVP and Chief Financial Officer
Option
26 Feb 2021
$27.35 $26,666
Denise M. Bohnert
Chief Compliance Officer
Prodej
25 Feb 2021
$274.44 $19,211
Denise M. Bohnert
Chief Compliance Officer
Option
20 Jan 2021
$46.35 $24,380
Denise M. Bohnert
Chief Compliance Officer
Prodej
25 Jan 2021
$314.41 $142,742
Scott G Ginn
Chief Financial Officer
Option
29 Jan 2021
$27.35 $26,666
David L Kemmerly
See Remarks
Option
17 Feb 2021
$295.20 $1,002,499
Paul B. K. Kusserow
See Remarks
Option
17 Feb 2021
$295.20 $7,245,979
Scott G Ginn
Chief Financial Officer
Option
17 Feb 2021
$295.20 $1,484,856
Michael Paul North
Chief Information Officer
Option
17 Feb 2021
$295.20 $1,002,499
Denise M. Bohnert
Chief Compliance Officer
Option
17 Feb 2021
$295.20 $593,942
Sharon Brunecz
Chief Human Resources Officer
Option
17 Feb 2021
$295.20 $2,240,273
Christopher Gerard
Chief Operating Officer
Option
17 Feb 2021
$295.20 $4,169,995
Denise M. Bohnert
Chief Compliance Officer
Prodej
20 Feb 2021
$291.48 $36,726

Diskuze k akciím AMED